Sun Pharmaceutical Aims To Keep Rivals In The Rearview Mirror
This article was originally published in PharmAsia News
Executive Summary
India’s Sun Pharmaceuticals says it is set to keep sales volumes growing in part through an aggressive acquisition strategy and a more diversified mix of products after third quarter profit more than quadruples.